Kimberly Clark Corp (KMB), McDonald’s Corporation (MCD), Pfizer Inc. (PFE): Three Long-Term Stocks With Juicy Dividend Yields

Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE), the world’s largest pharmaceutical company, is the owner of several global leading pharmaceutical brands, including Lipitor, Viagra and Lyrica. It operates in five main segments: Primary Care, Specialty Care and Oncology, Established Products and Emerging Markets, Animal Health and Consumer Healthcare. Most of its revenue, $20.2 billion, was generated from the Established Products and Emerging Markets segment. The Primary Care segment ranked second with $15.6 billion in sales, while the Specialty Care and Oncology segment contributed $15.45 billion in revenue.

Pfizer Inc. (NYSE:PFE) has consistently paid increasing dividends. The dividend rose from $0.60 per share in 2003 to $0.88 per share in 2012. The company has the quite conservative capital structure, with the debt/equity ratio at only 0.4. Pfizer Inc. (NYSE:PFE) is trading at $27.70 per share, with the total market cap of $196.8 billion. The market values the company at only 7.8 times EV/EBITDA. Interestingly, it offers its shareholders quite juicy dividend yield, at 3.5%.

My Foolish take

Income long-term investors should really consider three of those above-mentioned stocks for their portfolios. Even with the short-term downturn in the market, those three businesses, with their global leading positions and decent operating performance, will benefit investors well in a long run.

Anh HOANG has no position in any stocks mentioned. The Motley Fool recommends Kimberly-Clark and McDonald’s. The Motley Fool owns shares of McDonald’s.

The article Three Long-Term Stocks With Juicy Dividend Yields originally appeared on Fool.com and is written by Anh HOANG.

Anh is a member of The Motley Fool Blog Network — entries represent the personal opinion of the blogger and are not formally edited.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.